![](/assets/images/down.png)
![](/assets/images/up.png)
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-05-10 | 2022-03 | -0.12 | N/A | N/A | N/A |
2022-03-28 | 2021-12 | -0.13 | N/A | N/A | N/A |
2021-11-10 | 2021-09 | -0.47 | N/A | N/A | N/A |
2021-08-12 | 2021-06 | -0.8 | N/A | N/A | N/A |
2021-05-13 | 2021-03 | -0.83 | N/A | N/A | N/A |
2021-03-18 | 2020-12 | -0.76 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2021-10-14 | HC Wainwright & Co. | Upgrade | Buy | |
2021-06-03 | Raymond James | Downgrade | Outperform | Market Perform |
2021-06-03 | Baird | Downgrade | Outperform | Neutral |
2021-05-17 | Wells Fargo | Upgrade | Underweight | |
2021-05-14 | Raymond James | Upgrade | Outperform | |
2021-02-08 | Wells Fargo | Downgrade | Overweight | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-06-13 | ATHYRIUM OPPORTUNITIES FUND A, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2021-06-13 | BIGALKE JOHN T | Director | 47.52K | Stock Award(Grant) |
2022-04-14 | D'ESPARBES ERIC | Chief Financial Officer | 423.17K | Stock Award(Grant) |
2021-11-02 | HOWE JILL ANN | Director | 76.75K | Stock Award(Grant) |
2021-06-13 | KOTZIN BRIAN L | Director | 47.52K | Stock Award(Grant) |
2021-11-07 | MOHANTY ADITYA P | Chief Executive Officer | 1.41M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Athyrium Capital Management, LP | 29.86M | 62.40M | 16.21% |
2022-03-30 | Neuberger Berman Group, LLC | 6.54M | 7.59M | 3.55% |
2022-03-30 | Vanguard Group, Inc. (The) | 5.16M | 5.98M | 2.80% |
2022-03-30 | Blackrock Inc. | 1.66M | 1.93M | 0.90% |
2022-03-30 | Geode Capital Management, LLC | 1.15M | 1.34M | 0.63% |
2022-03-30 | Susquehanna International Group, LLP | 955.32K | 1.11M | 0.52% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | Vanguard Total Stock Market Index Fund | 3.03M | 6.32M | 1.64% |
2021-12-30 | Vanguard Extended Market Index Fund | 1.58M | 3.29M | 0.86% |
2022-02-27 | Fidelity Extended Market Index Fund | 615.33K | 830.69K | 0.33% |
2022-02-27 | Fidelity Total Market Index Fund | 210.77K | 284.53K | 0.11% |
2022-02-27 | Fidelity Series Total Market Index Fund | 121.33K | 163.79K | 0.07% |
2022-02-27 | Fidelity NASDAQ Composite Index Fund | 80.80K | 109.08K | 0.04% |
-
There are no shares left available to borrow. That’s why shorts can’t bring PROG below $2.50. Wahahaha.
-
No shares left to borrow for those sick retail shorts. Wahahaha. Get ready for the rockets.
-
As hard as shorts may try, shorts fail to bring PROG down below $2.50. PROG also didn’t go below $1 either. Chart looks bullish. Think. Don’t listen to FUDs
-
@Luvmypup is a retail short creating FUDs.
Progenity is currently partnering with Pfizer and Abbvie in studies to boost efficacy of FDA approved drugs. PROG is developing device and patents to boost drug efficacy. We are waiting for data from Phase 4 clinical trials this month. Previous data looks good in animal models. We expect the same for human trials.
-
@Luvmypup has short positions at $2.15. I know you wanted PROG to go below $2.50, $1, and zero. So I just bought another 70,000 shares. I want your house and your car dude. But you will also lose your wife when PROG goes to $10.
-
It will be so funny if PROG start ripping tomorrow when all hopes were given up
-
Fake News have now turned to writing professional hit jobs against retail stocks. We Only BUY and HODL.
-
We loved the stock. We BUY and WE HODL
-
If we are Diamond handing this, y’all won’t see $2 ever again. So you can stop wasting your time waiting.
-
Whenever volume is dead, we bleed. This is so messed up.
-
Extremely low volume. No one is selling. Algorithm doesn’t know what to do
-
Just think of Black Friday. What do you do ? Go shopping. Buy them up
-
Well another 17,000 shares to average down. Thanks for the cheapies
-
We will pass BBIG soon
-
PROG is Green in a Sea of RED
-
PROG is bullish today and likely close above $3
-
If it is REd in premarket, PROG will make a run during the market hours.
-
Market took another dump today
-
Bear thesis is dead. PROG maintain a higher low and consolidated sideway yesterday. Gets ready for the rockets and the next leg up.
-
Progenity Announces Successful Transfer of Liquid Biopsy Technologies
globenewswire.com • -
Progenity to Become Biora Therapeutics as it Completes Transformation
globenewswire.com • -
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
globenewswire.com • -
Should You Invest in These Penny Stocks Next Month? 3 to Watch
pennystocks.com • -
Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch This Week
pennystocks.com • -
Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022
globenewswire.com • -
Top Penny Stocks to Buy Right Now? 3 to Watch in Mid-February
pennystocks.com • -
Top Reddit Penny Stocks That Investors Are Watching Right Now
pennystocks.com • -
3 Penny Stocks Climbing During Today's Trading Session
pennystocks.com • -
These 4 Penny Stocks Exploded Today, Here's Why
pennystocks.com • -
Here's 3 Trending Penny Stocks to Add to Your Watchlist in February
pennystocks.com • -
5 Top Penny Stocks To Buy Now According To Reddit
pennystocks.com •